BioCentury | Feb 9, 2009
Finance

Ebb & Flow

...Last year, the investor proposed to cap the board size at 12. Icahn Capital and Icahn Associates...
BioCentury | Sep 25, 2006
Company News

ImClone board of directors update

...ImClone Systems Inc. (IMCL), New York, N.Y. Business: Cancer Appointed: Carl Icahn, chairman of Icahn Associates; Richard...
BioCentury | Feb 24, 2003
Company News

Cadus Pharmaceutical Corp. management update

...director Hired: Michele Paige as CEO, president and a director, formerly an investment associate at Icahn Associates...
BioCentury | Feb 27, 2002
Financial News

Glass resigns from Icahn Associates

...Russell Glass resigned as president and chief investment officer of Icahn Associates, an investment firm owned by...
...19). Although media reports have tied Glass's departure to Carl Icahn's recent dealings with IMCL, Icahn Associates...
BioCentury | Apr 2, 2001
Company News

Axiom board of directors update

...director of the leukemia service at the New York Presbyterian Hospital; Russell Glass, president of Icahn Associates...
BioCentury | Apr 24, 2000
Company News

Cadus Pharmaceutical Corp. management update

...Hired: Russell Glass as interim president and CEO, while remaining a director and president of Icahn Associates WIR...
Items per page:
1 - 6 of 6
BioCentury | Feb 9, 2009
Finance

Ebb & Flow

...Last year, the investor proposed to cap the board size at 12. Icahn Capital and Icahn Associates...
BioCentury | Sep 25, 2006
Company News

ImClone board of directors update

...ImClone Systems Inc. (IMCL), New York, N.Y. Business: Cancer Appointed: Carl Icahn, chairman of Icahn Associates; Richard...
BioCentury | Feb 24, 2003
Company News

Cadus Pharmaceutical Corp. management update

...director Hired: Michele Paige as CEO, president and a director, formerly an investment associate at Icahn Associates...
BioCentury | Feb 27, 2002
Financial News

Glass resigns from Icahn Associates

...Russell Glass resigned as president and chief investment officer of Icahn Associates, an investment firm owned by...
...19). Although media reports have tied Glass's departure to Carl Icahn's recent dealings with IMCL, Icahn Associates...
BioCentury | Apr 2, 2001
Company News

Axiom board of directors update

...director of the leukemia service at the New York Presbyterian Hospital; Russell Glass, president of Icahn Associates...
BioCentury | Apr 24, 2000
Company News

Cadus Pharmaceutical Corp. management update

...Hired: Russell Glass as interim president and CEO, while remaining a director and president of Icahn Associates WIR...
Items per page:
1 - 6 of 6